EUR 175.53 at Lang & Schwarz: Galderma stock pre-market plus 0.11 percent versus the prior close
Published on 10/09/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Galderma stock was at EUR 175.53 pre-market at Lang & Schwarz.
- The price was up 0.11 percent versus the October 8 prior close.
- The Fall Clinical 2026 conference continues through October 11, 2026.
Galderma stock was at EUR 175.53 pre-market at Lang & Schwarz at 8:26 a.m. CEST on October 9, 2026. The price was up EUR 0.20, or plus 0.11 percent, versus the prior close at Lang & Schwarz of EUR 175.33 on October 8, 2026. The bid was EUR 174.75 and the ask was EUR 176.30. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Galderma stock.
What matters today
Galderma is scheduled to participate in the Fall Clinical 2026 conference, which runs through October 11, 2026, with a company-sponsored product theatre listed for October 9 at 12:30 p.m. CEST by BioSpace. A move to the round level of EUR 180.00 would place the stock 2.55 percent above the pre-market price. The latest cited P/E ratio was 48.0 as of October 8, 2026.
Pre-market trading
The quote remains before the regular Xetra session, with the spread between the bid and ask at EUR 1.55. The Lang & Schwarz indication is separate from company developments and does not establish a reason for the price change.
Market context: Market report SMI.
